 Neelanjan Mukherjee
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 13 | 2023 | 362 | 2.540 |
Why?
| | RNA, Messenger | 14 | 2021 | 2574 | 1.710 |
Why?
| | RNA | 8 | 2023 | 819 | 1.670 |
Why?
| | Transcriptome | 7 | 2021 | 736 | 1.240 |
Why?
| | Pteridines | 1 | 2023 | 21 | 0.880 |
Why?
| | Gene Expression Regulation | 7 | 2019 | 2353 | 0.860 |
Why?
| | Aldehydes | 1 | 2023 | 144 | 0.820 |
Why?
| | Aldosterone | 1 | 2021 | 42 | 0.780 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 148 | 0.740 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 157 | 0.720 |
Why?
| | Ribonucleoproteins | 3 | 2019 | 87 | 0.720 |
Why?
| | ELAV-Like Protein 1 | 6 | 2021 | 20 | 0.640 |
Why?
| | HEK293 Cells | 8 | 2019 | 602 | 0.540 |
Why?
| | Antigens, Surface | 3 | 2011 | 151 | 0.540 |
Why?
| | RNA, Untranslated | 1 | 2016 | 113 | 0.500 |
Why?
| | Tristetraprolin | 1 | 2014 | 5 | 0.460 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1536 | 0.450 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 2011 | 81 | 0.450 |
Why?
| | Sequence Analysis, RNA | 6 | 2019 | 390 | 0.430 |
Why?
| | RNA Stability | 1 | 2011 | 93 | 0.360 |
Why?
| | Binding Sites | 6 | 2019 | 1177 | 0.360 |
Why?
| | RNA Precursors | 1 | 2011 | 136 | 0.350 |
Why?
| | MicroRNAs | 6 | 2019 | 607 | 0.320 |
Why?
| | Computational Biology | 4 | 2018 | 536 | 0.270 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1057 | 0.250 |
Why?
| | T-Lymphocytes | 2 | 2009 | 1756 | 0.240 |
Why?
| | Immunoprecipitation | 3 | 2014 | 154 | 0.230 |
Why?
| | ELAV Proteins | 3 | 2011 | 17 | 0.200 |
Why?
| | 3' Untranslated Regions | 2 | 2021 | 136 | 0.200 |
Why?
| | Ribosomes | 2 | 2015 | 148 | 0.190 |
Why?
| | Argonaute Proteins | 2 | 2019 | 28 | 0.190 |
Why?
| | Angiotensin II | 1 | 2021 | 91 | 0.190 |
Why?
| | Software | 3 | 2018 | 541 | 0.190 |
Why?
| | Molecular Sequence Annotation | 2 | 2019 | 82 | 0.180 |
Why?
| | Interferons | 1 | 2021 | 152 | 0.180 |
Why?
| | Proteome | 1 | 2023 | 345 | 0.170 |
Why?
| | Hydrocortisone | 1 | 2021 | 273 | 0.170 |
Why?
| | Herpesvirus 8, Human | 2 | 2011 | 63 | 0.170 |
Why?
| | Humans | 23 | 2021 | 115587 | 0.170 |
Why?
| | Open Reading Frames | 2 | 2016 | 116 | 0.170 |
Why?
| | Base Sequence | 3 | 2019 | 2114 | 0.160 |
Why?
| | Drosophila melanogaster | 2 | 2019 | 190 | 0.160 |
Why?
| | Nucleotide Motifs | 1 | 2018 | 30 | 0.160 |
Why?
| | RNA Splicing | 2 | 2017 | 244 | 0.160 |
Why?
| | Gene Expression | 2 | 2016 | 1435 | 0.160 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 548 | 0.160 |
Why?
| | RNA, Antisense | 2 | 2019 | 16 | 0.150 |
Why?
| | Drosophila Proteins | 1 | 2019 | 159 | 0.150 |
Why?
| | DEAD-box RNA Helicases | 1 | 2017 | 55 | 0.140 |
Why?
| | RNA, Long Noncoding | 1 | 2019 | 157 | 0.140 |
Why?
| | Protein Biosynthesis | 3 | 2015 | 390 | 0.140 |
Why?
| | RNA, Viral | 2 | 2011 | 565 | 0.140 |
Why?
| | Cells, Cultured | 2 | 2021 | 3914 | 0.130 |
Why?
| | Neoplasm Proteins | 2 | 2017 | 385 | 0.130 |
Why?
| | Phenotype | 1 | 2023 | 2829 | 0.130 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 544 | 0.120 |
Why?
| | DNA Damage | 1 | 2017 | 357 | 0.120 |
Why?
| | Genome, Human | 1 | 2016 | 352 | 0.110 |
Why?
| | RNA, Plant | 1 | 2013 | 9 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 135 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2010 | 746 | 0.110 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2012 | 18 | 0.110 |
Why?
| | Protein Interaction Mapping | 1 | 2013 | 102 | 0.100 |
Why?
| | Arabidopsis | 1 | 2013 | 79 | 0.100 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2012 | 61 | 0.100 |
Why?
| | Nanoparticles | 1 | 2016 | 316 | 0.100 |
Why?
| | Lymphoma, Primary Effusion | 1 | 2011 | 3 | 0.100 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1310 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1147 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 407 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 198 | 0.090 |
Why?
| | Nuclear Factor 90 Proteins | 1 | 2010 | 1 | 0.090 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2009 | 5 | 0.090 |
Why?
| | Stilbenes | 1 | 2009 | 36 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2009 | 128 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2194 | 0.080 |
Why?
| | Thymus Gland | 1 | 2009 | 299 | 0.080 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2007 | 150 | 0.070 |
Why?
| | Cell Line, Tumor | 5 | 2016 | 2751 | 0.070 |
Why?
| | Algorithms | 1 | 2013 | 1490 | 0.070 |
Why?
| | Kinetics | 1 | 2009 | 1569 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2017 | 1872 | 0.070 |
Why?
| | rho GTP-Binding Proteins | 1 | 2006 | 62 | 0.060 |
Why?
| | Radiation Tolerance | 1 | 2006 | 92 | 0.060 |
Why?
| | Polyadenylation | 2 | 2017 | 37 | 0.060 |
Why?
| | Adenoviridae | 1 | 2005 | 186 | 0.060 |
Why?
| | Neoplasm Invasiveness | 1 | 2006 | 445 | 0.060 |
Why?
| | Paclitaxel | 1 | 2005 | 192 | 0.060 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 174 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2005 | 181 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2790 | 0.060 |
Why?
| | Animals | 10 | 2019 | 32102 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2651 | 0.060 |
Why?
| | Glioblastoma | 1 | 2006 | 253 | 0.050 |
Why?
| | RNA Interference | 2 | 2016 | 438 | 0.050 |
Why?
| | Multigene Family | 2 | 2014 | 193 | 0.050 |
Why?
| | Signal Transduction | 3 | 2016 | 4541 | 0.050 |
Why?
| | Mice | 6 | 2016 | 15052 | 0.050 |
Why?
| | Evolution, Molecular | 2 | 2019 | 440 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 930 | 0.040 |
Why?
| | Substrate Specificity | 2 | 2012 | 357 | 0.040 |
Why?
| | Introns | 1 | 2019 | 226 | 0.040 |
Why?
| | Prostatic Neoplasms | 1 | 2005 | 927 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2006 | 980 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2017 | 73 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1044 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 190 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 231 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 850 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 324 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 252 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2014 | 352 | 0.030 |
Why?
| | Plant Roots | 1 | 2013 | 36 | 0.030 |
Why?
| | Systems Integration | 1 | 2013 | 38 | 0.030 |
Why?
| | Genome, Plant | 1 | 2013 | 44 | 0.030 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2013 | 48 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 301 | 0.030 |
Why?
| | Epigenomics | 1 | 2013 | 105 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 327 | 0.030 |
Why?
| | Response Elements | 1 | 2012 | 83 | 0.030 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 57 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2012 | 182 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2013 | 187 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 324 | 0.020 |
Why?
| | Signal-To-Noise Ratio | 1 | 2011 | 57 | 0.020 |
Why?
| | Ovary | 1 | 2012 | 190 | 0.020 |
Why?
| | Macaca | 1 | 2010 | 51 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2011 | 208 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2000 | 0.020 |
Why?
| | Operon | 1 | 2010 | 59 | 0.020 |
Why?
| | Brain | 2 | 2012 | 2370 | 0.020 |
Why?
| | Regulon | 1 | 2010 | 33 | 0.020 |
Why?
| | Eukaryotic Cells | 1 | 2010 | 33 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 281 | 0.020 |
Why?
| | Chromatin | 1 | 2013 | 429 | 0.020 |
Why?
| | Receptors, Death Domain | 1 | 2009 | 3 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 398 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 339 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 776 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3466 | 0.020 |
Why?
| | Female | 4 | 2017 | 59913 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 1917 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 443 | 0.020 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2007 | 8 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2007 | 24 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 214 | 0.020 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2007 | 39 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2008 | 219 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2007 | 181 | 0.020 |
Why?
| | Species Specificity | 1 | 2008 | 552 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 4773 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 567 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2006 | 58 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2800 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2006 | 245 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2005 | 42 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 553 | 0.020 |
Why?
| | Stem Cells | 1 | 2009 | 546 | 0.020 |
Why?
| | Caspases | 1 | 2005 | 245 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 482 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 332 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 793 | 0.010 |
Why?
| | Mice, Nude | 1 | 2005 | 639 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2005 | 260 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 866 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1153 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 773 | 0.010 |
Why?
| | ErbB Receptors | 1 | 2006 | 557 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 820 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3364 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 1700 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2008 | 1093 | 0.010 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2005 | 638 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1646 | 0.010 |
Why?
| | Male | 3 | 2014 | 55949 | 0.010 |
Why?
| | Rats | 1 | 2006 | 5034 | 0.010 |
Why?
| | Apoptosis | 1 | 2005 | 2377 | 0.010 |
Why?
| | Child | 1 | 2012 | 18488 | 0.010 |
Why?
| | Adult | 1 | 2014 | 30718 | 0.010 |
Why?
|
|
Mukherjee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|